ACADIA Pharmaceuticals Inc
Pharmaceutical & medical device company payment data from CMS Open Payments.
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $66.9M | 10,281 | 68.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $17.2M | 6,830 | 17.6% |
| Consulting Fee | $6.8M | 2,302 | 7.0% |
| Food and Beverage | $3.7M | 148,008 | 3.8% |
| Travel and Lodging | $2.3M | 8,965 | 2.4% |
| Grant | $1.1M | 28 | 1.1% |
| Education | $23,289 | 3,408 | 0.0% |
| Space rental or facility fees (teaching hospital only) | $2,000 | 1 | 0.0% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| ACP-103-046 | $7.1M | 12 | 469 |
| ACP-2566-003 | $4.2M | 15 | 648 |
| ACP-103-059 | $4.1M | 3 | 393 |
| ACP-103-047 | $4.0M | 10 | 415 |
| ACP-103-045 | $3.8M | 25 | 428 |
| ACP-044-004 | $3.8M | 0 | 68 |
| ACP-103-069 | $3.5M | 0 | 270 |
| ACP-103-042 | $3.4M | 32 | 534 |
| ACP-2566-004 | $2.7M | 0 | 302 |
| ACP-044-005 | $2.4M | 0 | 361 |
| ACP-204-006 | $2.2M | 0 | 482 |
| ACP-103-055 | $2.0M | 1 | 392 |
| ACA 16-cAC-0001 | $1.9M | 77 | 452 |
| ACP-103-070 | $1.8M | 0 | 280 |
| ACP-103-050 | $1.7M | 0 | 37 |
| ACP-103-034 | $1.6M | 50 | 1,157 |
| ACP-2566-005 | $1.6M | 0 | 245 |
| ACP-103-040 | $1.6M | 1 | 21 |
| ACP-103-053 | $1.5M | 0 | 5 |
| ACP-101-302 | $1.5M | 0 | 67 |
| ACP-103-038 | $1.2M | 38 | 588 |
| ACP-103-063 | $1.2M | 7 | 313 |
| ACP-103-035 | $1.2M | 49 | 813 |
| ACP-103-048 | $965,547 | 19 | 177 |
| ACP-103-032 | $933,376 | 33 | 257 |
| ACP-101-303 | $862,294 | 0 | 25 |
| ACP-2566-009 | $794,964 | 0 | 95 |
| ACP-103-033 | $642,060 | 20 | 184 |
| ACP-103-056 | $538,299 | 10 | 178 |
| ACP-103-049 | $490,402 | 1 | 1 |
Payments by Medical Specialty
Top Paid Doctors — Page 2
| Doctor | Specialty | Location | Total | 2019 |
|---|---|---|---|---|
| Dr. Anthony Giampolo, M.d, M.D | Neurology | Somerset, PA | $276,615 | $0 |
| Mr. Gerald Calegan, Md, MD | Internal Medicine | Baton Rouge, LA | $268,203 | $0 |
| Jose Gamez, M.d, M.D | Psychiatry | Hialeah, FL | $260,014 | $0 |
| Dr. Leslie Citrome, Md, Mph, MD, MPH | Psychiatry | Pomona, NY | $255,704 | $0 |
| Dr. Salima Brillman, Md, MD | Psychiatry | Sunnyvale, CA | $253,534 | $0 |
| Dr. Ashok Patel, M.d, M.D | Specialist | Toms River, NJ | $252,901 | $0 |
| Horacio Capote, M.d, M.D | Psychiatry | Amherst, NY | $246,675 | $0 |
| Mohammed Bari, M.d, M.D | Psychiatry | National City, CA | $246,301 | $0 |
| Mr. Zoltan Mari, Md, MD | Neurology | Las Vegas, NV | $244,168 | $0 |
| William Ondo, M.d, M.D | Neurology | Houston, TX | $241,152 | $0 |
| Malcolm Fraser, Md, MD | Geriatric Medicine | Brooksville, FL | $235,504 | $0 |
| Pierre Tariot, Md, MD | Clinical Neurophysiology | Phoenix, AZ | $235,250 | $0 |
| Fernando Pagan | Neurology | Washington, DC | $233,334 | $0 |
| Dr. Michael Kwiat, Md, MD | Psychiatry | Beaver, PA | $229,202 | $0 |
| Dr. Sandeep Thakkar, D.o, D.O | Neurology | Irvine, CA | $222,468 | $0 |
| Theodore Ruza, Do Pc, DO PC | Psychiatry | West Bloomfield, MI | $217,441 | $0 |
| Dr. Martha Mcgraw, M.d, M.D | Neurology | Winfield, IL | $214,375 | $0 |
| Dr. Fiona Gupta, M.d, M.D | Neurology | Oradell, NJ | $212,579 | $0 |
| Joseph Jankovic, M.d, M.D | Neurology | Houston, TX | $202,500 | $0 |
| Dr. Howard Hassman, D.o, D.O | Family Medicine | Clementon, NJ | $202,135 | $0 |
| Dr. Jill Giordano Farmer, Do, DO | Neurology | Philadelphia, PA | $201,145 | $0 |
| John Joyce, M. D, M. D | Psychiatry | Jacksonville, FL | $200,449 | $0 |
| Mr. Lawrence Elmer, M.d, M.D | Neurology | Toledo, OH | $194,322 | $0 |
| Michael Downing, Md, MD | Psychiatry | Dallas, TX | $194,284 | $0 |
| Pinky Agarwal, Md, MD | Specialist | Kirkland, WA | $192,718 | $0 |
About ACADIA Pharmaceuticals Inc
ACADIA Pharmaceuticals Inc has made $98.0M in payments to 23,481 healthcare providers, recorded across 179,823 transactions in the CMS Open Payments database. In 2024, the company paid $10.2M. The top product by payment volume is NUPLAZID ($76.2M).
Payments were distributed across 230 medical specialties. The top specialty by payment amount is Neurology ($16.8M to 4,658 doctors).
Payment categories include: Food & Beverage ($3.7M), Consulting ($6.8M), Research ($66.9M), Travel & Lodging ($2.3M).
ACADIA Pharmaceuticals Inc is associated with 6 products in the CMS Open Payments database, including NUPLAZID, ACP-204, and ACP-101.